Piperine Enhances the Protective Effect of Curcumin Against 3-NP Induced Neurotoxicity: Possible Neurotransmitters Modulation Mechanism

Neurochemical Research

Volumn 40, Issue 8, 2015, Pages 1758-1766

  Singh, Shamsher ^a,b   Jamwal, Sumit ^a,b   Kumar, Puneet ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b I K GUJRAL PUNJAB TECHNICAL UNIVERSITY   (India)

Author keywords

3 Nitropropionic acid; Curcumin; Huntington s disease; Piperine

Indexed keywords

3 NITROPROPIONIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; CURCUMIN; DOPAMINE; GLUTATHIONE; HOMOVANILLIC ACID; INTERLEUKIN 1BETA; NEUROTRANSMITTER; NITRITE; NORADRENALIN; PIPERINE; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; 1,3 BENZODIOXOLE DERIVATIVE; 3-NITROPROPIONIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALKALOID; AMIDE; NEUROPROTECTIVE AGENT; NITRO DERIVATIVE; PIPERIDINE DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG POTENTIATION; GRIP STRENGTH; HUNTINGTON CHOREA; LIPID PEROXIDATION; LOCOMOTION; LONG TERM CARE; LOW DRUG DOSE; MALE; MOTOR COORDINATION; MOTOR PERFORMANCE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NITROSATIVE STRESS; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ROTAROD TEST; WALKING; ANIMAL; COMBINATION DRUG THERAPY; DRUG EFFECTS; MOTOR ACTIVITY; PHYSIOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ALKALOIDS; ANIMALS; BENZODIOXOLES; CURCUMIN; DRUG THERAPY, COMBINATION; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; NITRO COMPOUNDS; OXIDATIVE STRESS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PROPIONATES; RATS; RATS, WISTAR;

EID: 84939188648     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1658-2     Document Type: Article

References (29)

1. Kumar P, Kalonia H, Kumar A (2010) Cyclosporine a attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism. Int J Toxicol 29(3):318–325
2. Chakraborty J, Pandey M, Navneet A, Appukuttan T, Varghese M, Sreetama S et al (2014) Profilin-2 increased expression and its altered interaction with β-actin in the striatum of 3-nitropropionic acid-induced Huntington’s disease in rats. Neuroscience 281:216–228
3. Chen JY, Wang EA, Cepeda C, Levine MS (2013) Dopamine imbalance in Huntington’s disease: a mechanism for the lack of behavioral flexibility. Front Neurosci 7:114
4. Khan A, Jamwal S, Bijjem K, Prakash A, Kumar P (2015) Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats. Neuroscience 287:66–77
5. Colle D, Hartwig JM, Soares FAA, Farina M (2012) Probucol modulates oxidative stress and excitotoxicity in Huntington’s disease models in vitro. Brain Res Bull 87(4):397–405
6. Aggarwal BB, Deb L, Prasad S (2014) Curcumin differs from tetrahydrocurcumin for molecular targets. Signal Pathw Cell Responses Mol 20(1):185–205
7. Kumar P, Padi S et al (2007) Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp Clin Pharmacol 29(1):19–26
8. Ghalandarlaki N, Alizadeh AM et al (2014) Nanotechnology-applied curcumin for different diseases therapy. Biomed Res Int 2014:1–23
9. Sandhir R, Yadav A et al (2014) Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington’s disease. NeuroMol Med 16(1):106–118
10. Patil UK, Singh A et al (2011) Role of piperine as a bioavailability enhancer. Int J Recent Adv Pharm Res 4:16–23
11. Thangarajan S, Deivasigamani A, Natarajan SS, Krishnan P, Mohanan SK (2014) Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. Int J Neurosci 124(9):673–684
12. Plaa GL, Witschi H (1976) Chemicals, drugs, and lipid peroxidation. Annu Rev Pharmacol Toxicol 16(1):125–142
13. Daniel WL, Han MS, Lee J-S, Mirkin CA (2009) Colorimetric nitrite and nitrate detection with gold nanoparticle probes and kinetic end points. J Am Chem Soc 131(18):6362–6363
14. Koster J, Biemond P, Swaak A (1986) Intracellular and extracellular sulphydryl levels in rheumatoid arthritis. Ann Rheum Dis 45(1):44–46
15. Lowry OH, Rosebrough NJ et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
16. Sharma S, Deshmukh R (2014) Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats. Neuroscience 286:393–403
17. Kumar P, Kalonia H, Kumar A (2010) Cyclosporine a attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism. Int J Toxicol 29(3):318–325
18. Kumar P, Kalonia H, Kumar A (2011) Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington’s-like symptoms: a comparative study. J Psychopharmacol 25(10):1399–1411
19. Kumar P, Kalonia H, Kumar A (2012) Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol 674(2):265–274
20. Colle D, Santos DB, Moreira ELG, Hartwig JM, dos Santos AA, Zimmermann LT et al (2013) Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats. PloS ONE 8(6):e67658
21. Amor S, Puentes F, Baker D, Van Der Valk P (2010) Inflammation in neurodegenerative diseases. Immunology 129(2):154–169
22. Im A-R, Chae S-W, jun Zhang G, Lee M-Y (2014) Neuroprotective effects of Psoralea corylifolia Linn seed extracts on mitochondrial dysfunction induced by 3-nitropropionic acid. BMC Complement Altern Med 14(1):370
23. Túnez I, Tasset I, Pérez-De La Cruz V, Santamaría A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington’s disease: past, present and future. Molecules 15(2):878–916
24. Hsieh H-L, Yang C-M (2013) Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed Res Int 2013:1–18
25. Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F et al (2014) Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol Neurodegener 9(1):56
26. Müller E, Parati E, Panerai A, Cocchi D, Caraceni T (1979) Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington’s chorea. Neuroendocrinology 28(5):313–319
27. Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington’s disease. J Neurochem 95(6):1521–1540
28. Pant MK, Panthari P, Kharkwal A, Kharkwal H, Kharkwal H (2014). Curcumin: a wonder therapeutical drug. World J Pharm and Pharm Sci 3(6):374–396
29. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807–818